drugset
drugset / Trial / NCT00700999

Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)

NCT00700999 ↗

Phase 4 Completed 65 enrolled US Department of Veterans Affairs
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to examine if treatment of post-traumatic stress disorder in combat veterans with paroxetine changes brain responses as measured by functional magnetic resonance imaging and if brain responses can predict who will get better with treatment.

Timeline

Start
2008-10
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 20 mg Oral
Subject Paroxetine Small molecule 40 mg Oral

Indications

post-traumatic stress disorder